Clinical trial: The effect of Johrei on symptoms of patients with functional chest pain

A. Gasiorowska, T. Navarro-Rodriguez, R. Dickman, Christopher S Wendel, B. Moty, J. Powers, M. R. Willis, K. Koenig, Y. Ibuki, H. Thai, R. Fass

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: Patients with functional chest pain (FCP) represent a therapeutic challenge for practising physicians. Aim: To determine the efficacy of Johrei as compared to wait-list in improving symptoms of FCP patients. Methods: Patients with chest pain of noncardiac origin for at least 3 months were enrolled into the study. All patients had to have negative upper endoscopy, pH testing and oesophageal manometry prior to randomization. Subsequently, patients were randomized to either Johrei or wait-list control. Patients received 18 Johrei sessions from a Johrei practitioner for 6 weeks. Results: A total of 21 FCP patients enrolled into the Johrei group and 18 into the wait-list group. There was no difference in symptom intensity score between Johrei group and wait-list group at baseline (20.28 vs. 23.06, P = N.S.). However, there was a significant pre- and post-treatment reduction in symptom intensity in the Johrei group (20.28 vs. 7.0, P = 0.0023). There was no significant reduction in symptom intensity score between baseline and at the end of the study in the wait-list group (23.06 vs. 20.69, P = N.S.). Conclusion: This pilot study shows that Johrei may have a role in improving FCP symptoms; however, future studies are needed to compare Johrei treatment with sham Johrei or supportive care.

Original languageEnglish (US)
Pages (from-to)126-134
Number of pages9
JournalAlimentary Pharmacology and Therapeutics
Volume29
Issue number1
DOIs
StatePublished - Jan 2009

Fingerprint

Chest Pain
Clinical Trials
Manometry
Random Allocation
Endoscopy
Therapeutics
Placebos
Physicians

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Clinical trial : The effect of Johrei on symptoms of patients with functional chest pain. / Gasiorowska, A.; Navarro-Rodriguez, T.; Dickman, R.; Wendel, Christopher S; Moty, B.; Powers, J.; Willis, M. R.; Koenig, K.; Ibuki, Y.; Thai, H.; Fass, R.

In: Alimentary Pharmacology and Therapeutics, Vol. 29, No. 1, 01.2009, p. 126-134.

Research output: Contribution to journalArticle

Gasiorowska, A, Navarro-Rodriguez, T, Dickman, R, Wendel, CS, Moty, B, Powers, J, Willis, MR, Koenig, K, Ibuki, Y, Thai, H & Fass, R 2009, 'Clinical trial: The effect of Johrei on symptoms of patients with functional chest pain', Alimentary Pharmacology and Therapeutics, vol. 29, no. 1, pp. 126-134. https://doi.org/10.1111/j.1365-2036.2008.03859.x
Gasiorowska, A. ; Navarro-Rodriguez, T. ; Dickman, R. ; Wendel, Christopher S ; Moty, B. ; Powers, J. ; Willis, M. R. ; Koenig, K. ; Ibuki, Y. ; Thai, H. ; Fass, R. / Clinical trial : The effect of Johrei on symptoms of patients with functional chest pain. In: Alimentary Pharmacology and Therapeutics. 2009 ; Vol. 29, No. 1. pp. 126-134.
@article{c44994ee921248a995fa42390a4bf2f8,
title = "Clinical trial: The effect of Johrei on symptoms of patients with functional chest pain",
abstract = "Background: Patients with functional chest pain (FCP) represent a therapeutic challenge for practising physicians. Aim: To determine the efficacy of Johrei as compared to wait-list in improving symptoms of FCP patients. Methods: Patients with chest pain of noncardiac origin for at least 3 months were enrolled into the study. All patients had to have negative upper endoscopy, pH testing and oesophageal manometry prior to randomization. Subsequently, patients were randomized to either Johrei or wait-list control. Patients received 18 Johrei sessions from a Johrei practitioner for 6 weeks. Results: A total of 21 FCP patients enrolled into the Johrei group and 18 into the wait-list group. There was no difference in symptom intensity score between Johrei group and wait-list group at baseline (20.28 vs. 23.06, P = N.S.). However, there was a significant pre- and post-treatment reduction in symptom intensity in the Johrei group (20.28 vs. 7.0, P = 0.0023). There was no significant reduction in symptom intensity score between baseline and at the end of the study in the wait-list group (23.06 vs. 20.69, P = N.S.). Conclusion: This pilot study shows that Johrei may have a role in improving FCP symptoms; however, future studies are needed to compare Johrei treatment with sham Johrei or supportive care.",
author = "A. Gasiorowska and T. Navarro-Rodriguez and R. Dickman and Wendel, {Christopher S} and B. Moty and J. Powers and Willis, {M. R.} and K. Koenig and Y. Ibuki and H. Thai and R. Fass",
year = "2009",
month = "1",
doi = "10.1111/j.1365-2036.2008.03859.x",
language = "English (US)",
volume = "29",
pages = "126--134",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Clinical trial

T2 - The effect of Johrei on symptoms of patients with functional chest pain

AU - Gasiorowska, A.

AU - Navarro-Rodriguez, T.

AU - Dickman, R.

AU - Wendel, Christopher S

AU - Moty, B.

AU - Powers, J.

AU - Willis, M. R.

AU - Koenig, K.

AU - Ibuki, Y.

AU - Thai, H.

AU - Fass, R.

PY - 2009/1

Y1 - 2009/1

N2 - Background: Patients with functional chest pain (FCP) represent a therapeutic challenge for practising physicians. Aim: To determine the efficacy of Johrei as compared to wait-list in improving symptoms of FCP patients. Methods: Patients with chest pain of noncardiac origin for at least 3 months were enrolled into the study. All patients had to have negative upper endoscopy, pH testing and oesophageal manometry prior to randomization. Subsequently, patients were randomized to either Johrei or wait-list control. Patients received 18 Johrei sessions from a Johrei practitioner for 6 weeks. Results: A total of 21 FCP patients enrolled into the Johrei group and 18 into the wait-list group. There was no difference in symptom intensity score between Johrei group and wait-list group at baseline (20.28 vs. 23.06, P = N.S.). However, there was a significant pre- and post-treatment reduction in symptom intensity in the Johrei group (20.28 vs. 7.0, P = 0.0023). There was no significant reduction in symptom intensity score between baseline and at the end of the study in the wait-list group (23.06 vs. 20.69, P = N.S.). Conclusion: This pilot study shows that Johrei may have a role in improving FCP symptoms; however, future studies are needed to compare Johrei treatment with sham Johrei or supportive care.

AB - Background: Patients with functional chest pain (FCP) represent a therapeutic challenge for practising physicians. Aim: To determine the efficacy of Johrei as compared to wait-list in improving symptoms of FCP patients. Methods: Patients with chest pain of noncardiac origin for at least 3 months were enrolled into the study. All patients had to have negative upper endoscopy, pH testing and oesophageal manometry prior to randomization. Subsequently, patients were randomized to either Johrei or wait-list control. Patients received 18 Johrei sessions from a Johrei practitioner for 6 weeks. Results: A total of 21 FCP patients enrolled into the Johrei group and 18 into the wait-list group. There was no difference in symptom intensity score between Johrei group and wait-list group at baseline (20.28 vs. 23.06, P = N.S.). However, there was a significant pre- and post-treatment reduction in symptom intensity in the Johrei group (20.28 vs. 7.0, P = 0.0023). There was no significant reduction in symptom intensity score between baseline and at the end of the study in the wait-list group (23.06 vs. 20.69, P = N.S.). Conclusion: This pilot study shows that Johrei may have a role in improving FCP symptoms; however, future studies are needed to compare Johrei treatment with sham Johrei or supportive care.

UR - http://www.scopus.com/inward/record.url?scp=57649196009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57649196009&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2036.2008.03859.x

DO - 10.1111/j.1365-2036.2008.03859.x

M3 - Article

C2 - 18945261

AN - SCOPUS:57649196009

VL - 29

SP - 126

EP - 134

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 1

ER -